Article

A signaling pathway-driven bioinformatics pipeline for predicting therapeutics against emerging infectious diseases

2021-08-20

Abstract excerpt

<h4>Background: </h4> Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the etiological agent of coronavirus disease-2019 (COVID-19), is a novel Betacoronavirus that was first reported in Wuhan, China in December of 2019. The virus has since caused a worldwide pandemic that highlights the need to quickly identify potential prophylactic or therapeutic treatments that can reduce the signs, symptoms, and/...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 897297e5-caa5-59a6-94dd-f11dafb775da
DOI: 10.12688/f1000research.52412.2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A signaling pathway-driven bioinformatics pipeline for predicting therapeutics against emerging infectious diseasesDOI 10.12688/f1000research.52412.2Read

Identification of candidate repurposable drugs to combat COVID-19 using a signature-based approachSemantic proximity Read

Network bioinformatics analysis provides insight into drug repurposing for COVID-19Semantic proximity Read

Deciphering Novel SARS CoV-2 specific Disease Pathways from RNA Sequencing Data of COVID-19 Infected A549 Cells and Potential Therapeutics using Next Generation Knowledge Discovery PlatformsSemantic proximity Read

A Connectivity Map-Based Drug Repurposing Study and Integrative Analysis of Transcriptomic Profiling of SARS-CoV-2 InfectionSemantic proximity Read

Identification of new drug treatments to combat COVID19: A signature-based approach using iLINCSSemantic proximity Read

Modeling COVID-19 disease biology to identify drug treatment candidatesSemantic proximity Read

Computational analysis to repurpose drugs for COVID-19 based on transcriptional response of host cells to SARS-CoV-2Semantic proximity Read

Repurposing novel therapeutic candidate drugs for coronavirus disease-19 based on protein-protein interaction network analysisSemantic proximity Read

Mechanistic modeling of the SARS-CoV-2 disease mapSemantic proximity Read

Deciphering The Molecular Pathogenesis Behind Neurological Manifestations of SARS-CoV-2 And Drug Repurposing, A Systems Biology ApproachSemantic proximity Read

Multi-omics data integration and network-based analysis drives a multiplex drug repurposing approach to a shortlist of candidate drugs against COVID-19Semantic proximity Read

Identification of Drugs Targeting Multiple Viral and Human Proteins Using Computational Analysis for Repurposing Against COVID-19Semantic proximity Read